Swiss HIV, Cohort Study

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 9.

Journal Article

Hasse, B.; Iff, M.; Ledergerber, B.; Calmy, A.; Schmid, P.; Hauser, Christoph; Cavassini, M.; Bernasconi, E.; Marzolini, C.; Tarr, P. E.; Swiss HIV, Cohort Study; Furrer, Hansjakob; Gorgievski, Meri; Rauch, Andri; Stähelin, Cornelia Johanna (2014). Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study. Open Forum Infectious Diseases, 1(2), ofu040. Oxford University Press 10.1093/ofid/ofu040

Metzner, K. J.; Scherrer, A. U.; Preiswerk, B.; Joos, B.; von Wyl, V.; Leemann, C.; Rieder, P.; Braun, D.; Grube, C.; Kuster, H.; Böni, J.; Yerly, S.; Klimkait, T.; Aubert, V.; Furrer, Hansjakob; Battegay, M.; Vernazza, P. L.; Cavassini, M.; Calmy, A.; Bernasconi, E.; ... (2013). Origin of Minority Drug-Resistant HIV-1 Variants in Primary HIV-1 Infection. Journal of infectious diseases, 208(7), pp. 1102-1112. Oxford University Press 10.1093/infdis/jit310

Keiser, Olivia; Spycher, Ben; Rauch, Andri; Calmy, Alexandra; Cavassini, Matthias; Glass, Tracy R; Nicca, Dunja; Ledergerber, Bruno; Egger, Matthias; Swiss HIV, Cohort Study (2012). Outcomes of antiretroviral therapy in the Swiss HIV Cohort Study: latent class analysis. AIDS and behavior, 16(2), pp. 245-55. New York, N.Y.: Springer 10.1007/s10461-011-9971-5

van Sighem, Ard; Vidondo, Beatriz; Glass, Tracy R.; Bucher, Heiner C.; Vernazza, Pietro; Gebhardt, Martin; de Wolf, Frank; Derendinger, Steven; Jeannin, André; Bezemer, Daniela; Fraser, Christophe; Low, Nicola; Swiss HIV, Cohort Study (2012). Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study. PLoS ONE, 7(9), e44819. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0044819

Simmons, Ruth; Sharp, Colin; McClure, C Patrick; Rohrbach, Janine; Kovari, Helen; Frangou, Eleni; Simmonds, Peter; Irving, Will; Rauch, Andri; Bowness, Paul; Klenerman, Paul; Swiss HIV, Cohort Study (2012). Parvovirus 4 infection and clinical outcome in high-risk populations. Journal of infectious diseases, 205(12), pp. 1816-20. Cary, N.C.: Oxford University Press 10.1093/infdis/jis291

Wang, Qing; Young, Jim; Bernasconi, Enos; Cavassini, Matthias; Vernazza, Pietro; Hirschel, Bernard; Weber, Rainer; Furrer, Hansjakob; Stoeckle, Marcel; Bucher, Heiner C; Fux, Christoph Andreas; Swiss HIV, Cohort Study (2012). The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study. Antiviral therapy, 18(3), pp. 337-344. London: International Medical Press 10.3851/IMP2372

Schöni-Affolter, Franziska; Keiser, Olivia; Mwango, Albert; Stringer, Jeffrey; Ledergerber, Bruno; Mulenga, Lloyd; Bucher, Heiner C.; Westfall, Andrew O.; Calmy, Alexandra; Boulle, Andrew; Chintu, Namwinga; Egger, Matthias; Chi, Benjamin H.; Swiss HIV, Cohort Study; IeDEA, Southern Africa (2011). Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland. PLoS ONE, 6(12), e27919. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0027919

Wandeler, Gilles; Keiser, Olivia; Hirschel, Bernard; Günthard, Huldrych F; Bernasconi, Enos; Battegay, Manuel; Clerc, Olivier; Vernazza, Pietro L; Furrer, Hansjakob; Swiss HIV, Cohort Study (2011). A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA. PLoS ONE, 6(12), e27903. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0027903

Dataset

Sculier, Delphine; Wandeler, Gilles; Yerly, Sabine; Marinosci, Annalisa; Stoeckle, Marcel; Bernasconi, Enos; Braun, Dominique L; Vernazza, Pietro; Cavassini, Matthias; Buzzi, Marta; Metzner, Karin J; Decosterd, Laurent; Günthard, Huldrych F; Schmid, Patrick; Limacher, Andreas; Egger, Matthias; Calmy, Alexandra; Swiss HIV, Cohort Study (2020). Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL-HIV trial [Dataset]. University of Bern

This list was generated on Sun May 5 14:15:51 2024 CEST.
Provide Feedback